Effects of the AMP-activated protein kinase inhibitor compound C on the postconditioned rat heart

Journal of Physiological Sciences

Volumn 62, Issue 4, 2012, Pages 333-341

  Hermann, R ^a   Prendes, M G Marina ^a   Torresin, M E ^a   Velez D ^a   Savino, E A ^a   Varela, A ^a,b  

^a Laboratory of Free Radical Biology   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

AMP activated protein kinase; Compound C; Heart; Ischemia; Postconditioning

Indexed keywords

(6 (4 (2 PIPERIDIN 1 YLETHOXY)PHENYL)) 3 PYRIDIN 4 YLPYRAZOLO(1,5 A)PYRIMIDINE; (6-(4-(2-PIPERIDIN-1-YLETHOXY)PHENYL))-3-PYRIDIN-4-YLPYRAZOLO(1,5-A)PYRIMIDINE; CARRIER PROTEIN; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ANIMAL; ARTICLE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HEART MITOCHONDRION; ISCHEMIC POSTCONDITIONING; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RAT; REPERFUSION INJURY; WISTAR RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL SURVIVAL; FEMALE; GLUTATHIONE; GLUTATHIONE DISULFIDE; ISCHEMIC POSTCONDITIONING; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; PYRAZOLES; PYRIMIDINES; RATS; RATS, WISTAR;

EID: 84864619906     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-012-0209-8     Document Type: Article

References (35)

1. Marina Prendes MG, Hermann R, Torresin ME, Souto P, Tallis S, Savino EA, Varela A (2011) Involvement of energetic metabolism in the effects of ischemic postconditioning on the ischemicreperfused heart of fed and fasted rats. J Physiol Sci 61:303-312
2. Vinten-Johansen J, Yellon DM, Opie LH (2005) Postconditioning. A simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 112: 2085-2088 (Pubitemid 41475799)
3. Gateau-Roesch O, Argaud L, Ovize M (2006) Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res 70(2):264-273
4. Hausenloy DJ, Ong S-B, Yellon DM (2009) The mitochondrial permeability transition pore as a target for preconditioning and postconditioning. Basic Res Cardiol 104:189-202
5. Griffiths EJ, Halestrap AP (1995) Mitochondrial non-specific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J 307:93-98
6. Halestrap AP (2009) Mitochondria and reperfusion injury of the heart. A holey death but not beyond salvation. J Bioenerg Biomembr 41:113-121
7. Di Lisa F, Semenzato M, Carpi A, Menazza S, Kaludercic N, Menabo R, Canton M (2010) In: Monotti G (ed) Mitochondrial dysfunction in cell injury and cardiotoxicity. Non-cardiovascular drugs, 1st edn. Wiley, U.K.
8. Gross ER, Gross GJ (2006) Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res 70:212-221
9. Hausenloy DJ, Yellon DM (2007) Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116:173-191 (Pubitemid 47451505)
10. Dyck JRP, Lopaschuk GD (2006) AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574:95-112 (Pubitemid 43905800)
11. Towler MC, Hardie DG (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100:328-341
12. Kim AS, Miller EJ, Young LH (2009) AMP-activated protein kinase: a core signaling pathway in the heart. Acta Physiol 196: 37-53
13. Bouhidel O, Pons S, Souktani R, Zini R, Berdeaux A, Bijan Ghaleh B (2008) Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice. Am J Physiol 295(4):H1580-H1586
14. Paiva MA, Conçalves LM, Providência LA, Davidson SM, Yellon DM, Mocanu MM (2010) Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther 24(1):25-32
15. Tietze F (1969) Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Applications to mammalian blood and other tissues. Anal Biochem 27:502-522
16. Yagi K (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods Mol Biol 108:101-106
17. Strehler BL (1974) Adenosine-50-triphosphate and creatine phosphate: determination with luciferase. In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol 4, 2nd edn. Academic, New York. pp 2112-2115
18. Walaas O, Walaas E (1950) Effect of epinephrine on rat diaphragm. J Biol Chem 187:769-776
19. Oliveira PJ, Coxito PM, Rolo AP, Santos DL, Palmeira CM, Moreno JM (2001) Inhibitory effect of carvedilol in the highconductance state of the mitochondrial permeability transition pore. Eur J Pharmacol 412:231-237 (Pubitemid 32144938)
20. Argaud L, Gateau-Roesch O, Raisky O, Loufouat J, Robert D (2005) Postconditioning inhibits mitochondrial permeability transition. Circulation 111:194-197 (Pubitemid 40139731)
21. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R (2010) Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res 87:406-423
22. Cohen MV, Downey JM (2011) Ischemic postconditioning: from receptor to end-effector. Antioxid Redox Signal 14: 821-831
23. Halestrap AP, Clarke SJ, Javadov SA (2004) Mitochondrial permeability transition pore opening during myocardial reperfusion. A target for cardioprotection. Cardiovasc Res 61: 372-385 (Pubitemid 38210145)
24. Javadov S, Karmazyn M, Escobales N (2009) Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330:670-678
25. Marina Prendes MG, González MS, Torresin ME, Hermann R, Pascale NG, Jaitovich MM et al (2009) Involvement of mitochondrial permeability transition, glutathione status, pentose phosphate pathway and oxidative damage in the protective effect of fasting on the ischaemic-reperfused rat heart. Clin Exp Pharmacol Physiol 36(7):637-642
26. Connern CP, Halestrap AP (1994) Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium- sensitive non-specific channel. Biochem J 302:321-324 (Pubitemid 24280079)
27. Connern CP, Halestrap AP (1996) Chaotropic agents and increased matrix volume enhance binding of mitochondrial cyclophilin to the inner mitochondrial membrane and sensitize the mitochondrial permeability transition to Ca2+. Biochemistry 35:8172-8180 (Pubitemid 26234917)
28. Chen Z, Laser LH (1998) Evidence for mitochondrial uptake of glutathione dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther 285:608-618 (Pubitemid 28237440)
29. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG (1997) Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 33:243-257 (Pubitemid 27072627)
30. Ussher JR, Lopaschuk GD (2009) Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Res Cardiol 104:203-210
31. Goodwin GW, Taylor CS, Taegtmeyer H (1998) Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 273:29530-29539 (Pubitemid 28509960)
32. Tejero-Taldo MI, Caffrey JL, Sun J, Mallet RT (1998) Pyruvate potentiates b-adrenergic inotropism of stunned guinea-pig myocardium. J Mol Cell Cardiol 30:2327-2339 (Pubitemid 28549984)
33. Tejero-Taldo MI, Caffrey JL, Sun J, Mallet RT (1999) Antioxidant properties of pyruvate mediates its potentiation of b-adrenergic inotropism in stunned myocardium. J Mol Cell Cardiol 31:1863-1872 (Pubitemid 29458704)
34. Arad M, Seidman CE, Seidman JG (2007) AMP-activated protein kinase in the heart. Role during health and disease. Circ Res 100:474-488 (Pubitemid 46673257)
35. Carling D, Hardie DG (1989) The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1012:81-86 (Pubitemid 19154923)